Microdose Journal

Scientific News, Journal Papers, Studies for Microdosing for Mental Health

Menu
  • About MicrodoseJournal.com
  • Conferences
  • Contact
  • Find Psychedelic Therapy Providers:
  • News
  • Psychedelic Studies & Research Centers
  • Retreats
  • Scientific Papers
  • Video
Menu

Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.

Posted on January 5, 2020 by Research

Psychopharmacology (Berl). 2019 Nov 29. doi: 10.1007/s00213-019-05391-0. [Epub ahead of print] Moreton SG1, Szalla L2, Menzies RE3, Arena AF3. Author information 1School of Psychology, University of Wollongong, Wollongong, NSW, 2522, Australia. smoreton@uow.edu.au.2School of Psychology, University of Wollongong, Wollongong, NSW, 2522, Australia.3School of Psychology, University of Sydney, Camperdown, NSW, 2006, Australia. Abstract Psychedelic therapies can engender…

Read more

Decreased directed functional connectivity in the psychedelic state

Posted on January 5, 2020 by Research

LionelBarnettaSuresh D.MuthukumaraswamybRobin L.Carhart-HarriscAnil K.Sethahttps://doi.org/10.1016/j.neuroimage.2019.116462Get rights and content Under a Creative Commons licenseopen access Abstract Neuroimaging studies of the psychedelic state offer a unique window onto the neural basis of conscious perception and selfhood. Despite well understood pharmacological mechanisms of action, the large-scale changes in neural dynamics induced by psychedelic compounds remain poorly understood. Using source-localised,…

Read more

Who’s who in Psychedelic Medicine & Research

Posted on January 4, 2020January 4, 2020 by Research

Amanda Feilding: Pioneer at the Beckley Foundation – Oxfordshire, England. Forefront of Cannabis and LSD research. A countess whose lineage traces all the way back to Charles II of England. “Psychedelics are a key to unlock a deeper level of the psyche. They can transform the individual in ways that modern science is only just…

Read more

Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers

Posted on January 4, 2020January 4, 2020 by Research

David Erritzoe, James Smith, Patrick M Fisher, First Published February 28, 2019 Research Article Find in PubMed https://doi.org/10.1177/0269881119827891 Article information  : British Association for Psychopharmacology Abstract Background: Recent studies have suggested therapeutic benefits of psychedelics for a variety of mental health conditions. The understanding of how single psychedelic administrations can induce long-lasting effects are, in…

Read more

Psychedelic Studies

Posted on January 4, 2020January 6, 2020 by Research

Multidisciplinary Association for Psychedelic StudiesMAPShttps://maps.org Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana Beckley Foundationhttps://beckleyfoundation.org The Beckley Foundation is one of the few organisations in the…

Read more

New Research Institutions

Posted on January 4, 2020 by Research

University of TorontoPsychedelic Studies Program The Psychedelic Studies Research Program (PSRP) at the University of Toronto Mississauga is dedicated to understanding the effects of microdosing. The researchers at PSRP are a team of experts with varied backgrounds in neuroscience, clinical psychology, creative thinking, psychotherapy, and more.  The PSRP aims to gain an understanding of the potential…

Read more

Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers

Posted on January 4, 2020 by Research

Contributors: Thomas Anderson Rotem Petranker Le-Anh Dinh-Williams Daniel Rosenbaum Cory Weissman Emma Hapke Katrina Hui Norman Farb Date created: 2018-11-02 01:30 AM | Last Updated: 2018-11-06 10:34 PM Category: Project Description: Microdosing psychedelics – the regular consumption of small amounts of psychedelic substances such as LSD or psilocybin – is a growing trend in popular…

Read more

Paul Stamets Announces First of it’s Kind: Mobile Microdosing Study

Posted on January 4, 2020January 4, 2020 by Research

On November 15, 2019 Paul Stamets (legendary mycologist and researcher), introduced the launch of a novel micro-dosing study that will be delivered to participants via a smart phone application. It is said to be the world’s first mobile micro-dosing study. The app developed by Quantified Citizen provides a way for participants to take part anonymously…

Read more

A systematic study of microdosing psychedlics

Posted on January 4, 2020January 4, 2020 by Research

Vince Polito, Richard J. Stevenson Published: February 6, 2019 https://doi.org/10.1371/journal.pone.0211023 Abstract The phenomenon of ‘microdosing’, that is, regular ingestion of very small quantities of psychedelic substances, has seen a rapid explosion of popularity in recent years. Individuals who microdose report minimal acute effects from these substances yet claim a range of long-term general health and…

Read more

Psychedelic microdosing benefits and challenges: an empirical codebook

Posted on January 3, 2020January 4, 2020 by Research

Harm Reduction Journal: Published 10 July 2019 Research Open Access Published: 10 July 2019 Psychedelic microdosing benefits and challenges: an empirical codebook Thomas Anderson,  Rotem Petranker,  Adam Christopher,  Daniel Rosenbaum,  Cory Weissman,  Le-Anh Dinh-Williams,  Katrina Hui &  Emma Hapke  Harm Reduction Journal volume 16, Article number: 43 (2019) Cite this article 13k Accesses 1 Citations 122 Altmetric Metricsdetails Abstract Background Microdosing psychedelics is the practice of…

Read more

Clinical potential of psilocybin as a treatment for mental health conditions.

Posted on January 3, 2020January 4, 2020 by Research

US National Library of Medicine: National Institutes of Health Journal:  The Mental Health Clinician Ment Health Clin. 2017 Jan; 7(1): 24–28.Published online 2018 Mar 23. doi: 10.9740/mhc.2017.01.024PMCID: PMC6007659PMID: 29955494 Clinical potential of psilocybin as a treatment for mental health conditions Jeremy Daniel, PharmD, BCPS, BCPP1 and Margaret Haberman, PharmD, BCPP2 Author information Copyright and License information Disclaimer Abstract Psilocybin, a classic hallucinogen, is…

Read more
  • Previous
  • 1
  • 2

About This Site

The Microdose Journal provides scientific studies and articles relating to the phenomenon of microdosing for the improvement of mental health.  It is also a resource for major study centers, conferences, and therapy centers that utilize psychedelics.

Recent Posts

  • A Review of LSD Treatment in Alcoholism
  • Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
  • The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
  • The ethics of psychedelic research in disorders of consciousness
  • Psychedelic Support
  • Santa Cruz, California City Council Approves Decriminalization Measure Measure for Psychedelics
  • Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
  • Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions
  • Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being
  • The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving
© 2023 Microdose Journal | Powered by Minimalist Blog WordPress Theme